↑ Rising
Health
FDA raised conflict of interest concerns ahead of new peptide panel
The FDA's upcoming vote on peptide substances is under scrutiny due to conflict of interest concerns.
Apha
1 trends tracked about this subject — the full history, oldest to newest below.